Schmid P, Turner NC, Barrios CH, Isakoff SJ, et al. First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results. Clin Cancer Res 2023 Dec 7. doi: 10.1158/1078-0432.CCR-23-2084.
PMID: 38060199